Onco_background

Oncology Weekly News - September 15th 2025

Oncology Update : Ozuriftamab Phase 3, Libtayo 5-Year Data, INLEXZO Approval…


Onco_background

Oncology Weekly News - September 1st 2025

🔬🧬 Oncology Updates: Tevimbra EU Approval, KRAS G12C Fast Tracks, HER2-Low…


Onco_background

Oncology Weekly News - August 4th 2025

🔬🧬 Oncology Updates: Ivonescimab Approved, Imfinzi Fast Tracked, TEVIMBRA EU…


Vaccines

Vaccines Weekly Update - July 11th 2025

🔬💉 Vaccines Global Breakthroughs: Flu, Malaria, Cancer, COVID-19 and more In…


Onco_background

Oncology Weekly News - May 19th 2025

Latest breakthroughs in oncology research: FDA and EU Approvals, Key Trial Wins…


Women's_Health

Women's Health Weekly News - May 14th 2025

Women’s Health Watch: Breakthroughs and Innovations in cervical cancer…


Onco_background

Oncology Weekly News - May 12th 2025

🧬🚀 Latest breakthroughs in oncology research: Naxitamab, Enhertu, PD-L1, and…


Onco_background

Oncology Weekly News - May 5th 2025

🧬🚀 Latest breakthroughs in oncology research! 🏥✨ From innovative trial results…


Onco_background

Oncology Weekly News - April 21st 2025

🚨 Oncology Breakthroughs You Can’t Miss! 🚨 From pediatric approvals in…


Onco_background

Oncology Weekly News - April 14th 2025

🚨 Oncology Breakthroughs You Can’t Miss! 🚨 From powerful immunotherapy…


Onco_background

Oncology Weekly Update - March 10th 2025

🏥Oncology Update: Imfinzi, TEVIMBRA, Taletrectinib & New Trials Welcome to…


Onco_background

Oncology Weekly Update - March 3rd 2025

Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Vaccines & More This…


Privacy Preference Center